Friday, August 7, 2009

Surgeon General choice will put primary care at the forefront

Surgeon General choice will put primary care at the forefront
Dr. Regina Benjamin, President Obama's choice for Surgeon General, puts the face of primary care at the forefront of the Obama administration's healthcare reform efforts, experts say.

Internet-based therapy may treat insomnia
A new software that uses quizzes, stories, and games may help people who suffer from insomnia, experts say.

Diprivan not a treatment for sleep disorders: experts
According to a nurse employed by Michael Jackson, the pop singer had repeatedly asked her to give him the powerful IV anesthetic Diprivan to treat his insomnia, even though the drug is not approved for this use.

Sleep Deprivation 101: What You Should Know
In my previous blogs I have written about the importance of good sleep, but I don’t think we ever really explained the significance of sleep deprivation and the effects on society and the individual. I thought that it would be a good idea to go over some significant facts and figures to convince you of the importance of getting a good restful sleep and of the need to address sleep problems with your doctor.What is sleep deprivation?It is...

The Holy Grail of Biological Questions: Why Do We Sleep?
In this blog, I am going to deal with a question that has stumped some of the most talented researchers in the world.  That should hopefully get your attention- this vexing question seems simple, but represents the “holy grail” of biology.  The question: why do we sleep?  Consider this- we spend approximately one-third of lives doing it and scientists are still not quit sure why.  (Much of this and future blogs on...

Reid: No healthcare vote until after August recess
Senate Majority Leader Harry Reid says there will be no vote on healthcare reform before Congress takes its August break, a move that would go against President Obama's announced timetable for its vote.

Drugmakers pour $40 million into healthcare reform debate
Statistics show that the Pharmaceutical Research and Manufacturers of America (PhRMA), a lobbying group that represents 32 brandname drug companies, and its member companies have spent $40 million lobbying Congress as the lawmakers work to overhaul the U.S. healthcare system.